A carregar...

Review article: linaclotide for the management of irritable bowel syndrome with constipation

BACKGROUND: Irritable bowel syndrome with constipation (IBS-C) represents a significant burden to patients and healthcare systems due to its prevalence and lack of successful symptomatic resolution with established treatment options. Linaclotide 290 μg has recently been approved by the European Medi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Aliment Pharmacol Ther
Main Authors: Layer, P, Stanghellini, V
Formato: Artigo
Idioma:Inglês
Publicado em: BlackWell Publishing Ltd 2014
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4305214/
https://ncbi.nlm.nih.gov/pubmed/24433216
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/apt.12604
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!